Session » (1183–1199) Osteoarthritis – Clinical Poster II
-
Abstract Number: 1183
CoLchicine for Treatment of OsteoArthritis of the Knee—Updated Data from a Double-blind, Placebo-controlled Trial
-
Abstract Number: 1184
A Wearable-Sensor for Assessment of Gait and Chair Stand Patterns in People with Knee Osteoarthritis: Validation and Responsiveness to Treatment of a Potential Digital Biomarker
-
Abstract Number: 1185
Soluble Buffered Alendronate After Denosumab Discontinuation in Erosive Hand OA Patients
-
Abstract Number: 1186
Presence of Erosions Is Not a Risk Factor for the Development of Knee OA in a Hand OA Population: The Framingham OA Study
-
Abstract Number: 1187
Post-hoc Analysis of Individual Questions from the Australian/Canadian Osteoarthritis Hand Index from a Randomized, Double-blind, Placebo-controlled Trial of Patients with Hand OA
-
Abstract Number: 1188
Development of a Method to Isolate Functional Mitochondria and Assess Their Functionality and Integration in Joint Tissues: In Vitro and in Vivo Models
-
Abstract Number: 1189
Evaluating Neuropathic and Nociplastic Pain in Patients with Hip and Knee Osteoarthritis
-
Abstract Number: 1190
Worsening of Pain as Perceived by Patients Is Not Reflected by an Annual Standardized Questionnaire
-
Abstract Number: 1192
Autoimmune Thyroid Disease Associates with Symptomatic Hand Osteoarthritis in Older Persons in the Third National Health and Nutrition Examination Survey
-
Abstract Number: 1193
The Association of Peak Forces and Loading Rates During Walking with MRI-Based Structural Worsening of the Knee: The Multicenter Osteoarthritis Study
-
Abstract Number: 1194
Extent of Subregional Involvement of Subchondral Bone Marrow Lesions in Incident Knee OA Is Associated with Weight-Bearing Knee Pain
-
Abstract Number: 1195
Relationship of Depth-Specific Subchondral Bone Mineral Density to MRI Cartilage Worsening: The Multicenter Osteoarthritis Study